Global Partners LP (GLP)
NYSE: GLP · Real-Time Price · USD
50.21
+0.71 (1.43%)
Aug 8, 2025, 4:00 PM - Market closed
Revance Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
17,828 | 17,164 | 16,492 | 18,878 | 13,248 | 8,322 | Upgrade | |
Revenue Growth (YoY) | 3.74% | 4.07% | -12.64% | 42.49% | 59.20% | -36.39% | Upgrade |
Cost of Revenue | 16,701 | 16,062 | 15,474 | 17,735 | 12,487 | 7,553 | Upgrade |
Gross Profit | 1,126 | 1,102 | 1,019 | 1,143 | 761.7 | 768.84 | Upgrade |
Selling, General & Admin | 869.76 | 851.15 | 769.26 | 750.71 | 608.9 | 563.53 | Upgrade |
Operating Expenses | 876.97 | 859.43 | 777.39 | 759.56 | 619.61 | 574.37 | Upgrade |
Operating Income | 249.27 | 242.22 | 241.14 | 383.22 | 142.09 | 194.47 | Upgrade |
Interest Expense | -140.11 | -134.77 | -85.63 | -81.26 | -80.09 | -83.54 | Upgrade |
Earnings From Equity Investments | 2.63 | -1.51 | 2.5 | - | - | - | Upgrade |
EBT Excluding Unusual Items | 111.78 | 105.93 | 158.02 | 301.96 | 62.01 | 110.93 | Upgrade |
Merger & Restructuring Charges | - | - | - | -2.8 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 8.91 | 9.49 | 2.63 | 79.87 | 0.51 | -0.28 | Upgrade |
Asset Writedown | -0.7 | -0.49 | - | - | -0.38 | -1.93 | Upgrade |
Other Unusual Items | -2.8 | -2.63 | - | - | - | -7.16 | Upgrade |
Pretax Income | 117.2 | 112.3 | 160.64 | 379.03 | 62.13 | 101.56 | Upgrade |
Income Tax Expense | 3.52 | 4.61 | 8.14 | 16.82 | 1.34 | -0.12 | Upgrade |
Earnings From Continuing Operations | 113.67 | 107.69 | 152.51 | 362.21 | 60.8 | 101.68 | Upgrade |
Minority Interest in Earnings | -17.43 | -15.34 | -9.91 | -7.14 | -3.58 | -0.87 | Upgrade |
Net Income | 96.24 | 92.35 | 142.6 | 355.07 | 57.22 | 100.81 | Upgrade |
Preferred Dividends & Other Adjustments | 7.12 | 9.58 | 14.56 | 13.85 | 12.21 | 6.73 | Upgrade |
Net Income to Common | 89.12 | 82.77 | 128.04 | 341.22 | 45.01 | 94.08 | Upgrade |
Net Income Growth | -10.29% | -35.24% | -59.84% | 520.59% | -43.24% | 192.31% | Upgrade |
Shares Outstanding (Basic) | 34 | 34 | 34 | 34 | 34 | 34 | Upgrade |
Shares Outstanding (Diluted) | 34 | 34 | 34 | 34 | 34 | 34 | Upgrade |
Shares Change (YoY) | 0.39% | 0.88% | -0.01% | -0.68% | -0.09% | -0.09% | Upgrade |
EPS (Basic) | 2.63 | 2.45 | 3.77 | 10.06 | 1.33 | 2.77 | Upgrade |
EPS (Diluted) | 2.60 | 2.41 | 3.76 | 10.02 | 1.31 | 2.74 | Upgrade |
EPS Growth | -4.96% | -35.90% | -62.48% | 664.88% | -52.19% | 238.27% | Upgrade |
Free Cash Flow | 250.57 | -286.78 | 110.42 | 373.2 | -51.5 | 236.19 | Upgrade |
Free Cash Flow Per Share | 7.30 | -8.35 | 3.24 | 10.96 | -1.50 | 6.88 | Upgrade |
Dividend Per Share | 2.970 | 2.900 | 2.715 | 2.460 | 2.310 | 1.903 | Upgrade |
Dividend Growth | 5.51% | 6.81% | 10.37% | 6.49% | 21.42% | -8.09% | Upgrade |
Gross Margin | 6.32% | 6.42% | 6.18% | 6.05% | 5.75% | 9.24% | Upgrade |
Operating Margin | 1.40% | 1.41% | 1.46% | 2.03% | 1.07% | 2.34% | Upgrade |
Profit Margin | 0.50% | 0.48% | 0.78% | 1.81% | 0.34% | 1.13% | Upgrade |
Free Cash Flow Margin | 1.41% | -1.67% | 0.67% | 1.98% | -0.39% | 2.84% | Upgrade |
EBITDA | 393.23 | 381.91 | 351.23 | 488.01 | 244.33 | 294.6 | Upgrade |
EBITDA Margin | 2.21% | 2.23% | 2.13% | 2.58% | 1.84% | 3.54% | Upgrade |
D&A For EBITDA | 143.96 | 139.69 | 110.09 | 104.8 | 102.24 | 100.14 | Upgrade |
EBIT | 249.27 | 242.22 | 241.14 | 383.22 | 142.09 | 194.47 | Upgrade |
EBIT Margin | 1.40% | 1.41% | 1.46% | 2.03% | 1.07% | 2.34% | Upgrade |
Effective Tax Rate | 3.00% | 4.10% | 5.07% | 4.44% | 2.15% | - | Upgrade |
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.